Toxicity and Cosmesis outcome in hypofractionated radiation therapy for ductal carcinoma in situ of the breast after breast conserving surgery.

Phase 2

Completed

• Conditions: Ductal carcinoma of the breast; Hypofractionation radiation; Cosmesis outcome

• Registration Number: TCTR20191223001
• Lead Sponsor: Chulalongkorn hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-12-13
• Study Start: 2019-12-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 33

Inclusion Criteria

Age over 18
Pathologically confirm DCIS

Exclusion Criteria

Any prior diagnosis of invasive or ductal carcinoma in situ breast cancer in ipsilateral breast
Pregnancy
Active soft tissue disease; active systemic lupus, erythematosus, or any history of scleroderma, dermatomyositis with active rash
Medical, psychiatric or other condition that would prevent the patient from receiving protocol therapy or providing informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Breast cosmesis at 6 months 6 months EORTC scale

Secondary Outcome Measures

Name	Time	Method
Toxicities 1 and 6 months CTCAE